Featured News

Celiac Disease Foundation Young Investigator Award recipient Jocelyn Silvester, MD, publishes “A new diagnostic paradigm for celiac disease.”

The Celiac Disease Foundation’s article, “New Legislation Aims to Extend Nutrition Care to Chronic Conditions” was featured in Future of Personal Health.

A study led by Columbia University and Celiac Disease Foundation researchers examined probiotic use among celiac disease patients and was an Outstanding Poster Presenter recipient at the 2020 ACG Annual Scientific Meeting.

The Foundation is pleased to announce its partnership with Provention Bio to provide clinical trial recruitment for its Phase 2b PROACTIVE Celiac Study for PRV-015 (an anti-interleukin-15 monoclonal antibody).

CDF has been approved for a $100,000 funding award through the Eugene Washington PCORI Engagement Awards program. The funds will support the community convening of patient advocates, researchers, and other key stakeholders to create a roadmap for patient advocate engagement in research.

We have been hearing from our community about COVID-19 and celiac disease and about our work at the Celiac Disease Foundation during the pandemic. We have answered the most frequently asked questions in a short video for you. 

The Celiac Disease Foundation National Patient Advocacy Summit in Washington, DC will train participants to advocate on celiac disease public policy priorities to Members of Congress.

The Celiac Disease Foundation, the nation’s leading disease advocacy organization for celiac disease, announces the appointment of officers to its Board of Directors.

After decades of pleading with our federal government to take celiac disease as seriously as it does other diseases with comparable patient impact, yesterday, the U.S. House and Senate each passed, and President Trump has signed, the FY2020 Federal budget resolution.

CEO Marilyn G. Geller speaks at the 18th International Celiac Disease Symposium (ICDS).